Story perspectives

Prostate Cancer Screening Could Cut Deaths by 13%

11/1/2025

50 7

Summary

Story summary

A study published in the New England Journal of Medicine finds prostate cancer screening could reduce deaths by 13%.
Researchers analyzed data from 162,000 men over 23 years, finding one death prevented for every 456 screened.
The United Kingdom is considering a screening program, with a decision expected soon.
The National Institute for Health and Care Excellence (NICE) has approved abiraterone for high-risk metastatic prostate cancer, benefiting about 4,000 patients.

1 of 1

Story summary

A study published in the New England Journal of Medicine finds prostate cancer screening could reduce deaths by 13%.
Researchers analyzed data from 162,000 men over 23 years, finding one death prevented for every 456 screened.
The United Kingdom is considering a screening program, with a decision expected soon.
The National Institute for Health and Care Excellence (NICE) has approved abiraterone for high-risk metastatic prostate cancer, benefiting about 4,000 patients.